1. Home
  2. CYD vs PVLA Comparison

CYD vs PVLA Comparison

Compare CYD & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$46.34

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$144.13

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYD
PVLA
Founded
1951
2015
Country
Singapore
United States
Employees
N/A
29
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CYD
PVLA
Price
$46.34
$144.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
15
Target Price
$60.00
$171.87
AVG Volume (30 Days)
218.3K
290.1K
Earning Date
02-24-2026
05-12-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.11
N/A
Revenue Next Year
$8.67
$104,350.18
P/E Ratio
$32.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$21.27
$26.19
52 Week High
$61.48
$161.38

Technical Indicators

Market Signals
Indicator
CYD
PVLA
Relative Strength Index (RSI) 43.96 59.17
Support Level $40.34 $106.07
Resistance Level $56.55 $156.28
Average True Range (ATR) 2.89 10.13
MACD -0.06 1.21
Stochastic Oscillator 52.59 65.47

Price Performance

Historical Comparison
CYD
PVLA

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: